Literature DB >> 29108727

Reproducibility of serum oxysterols and lanosterol among postmenopausal women: Results from EPIC-Heidelberg.

Da-Lin Lu1, Disorn Sookthai1, Charlotte Le Cornet1, Verena A Katzke1, Theron S Johnson1, Rudolf Kaaks1, Renée T Fortner2.   

Abstract

BACKGROUND: Circulating oxysterols have been proposed as biological markers of disease risk. However, within-person reproducibility of circulating oxysterols over time is not well established.
METHODS: We evaluated the one-year reproducibility of 11 oxysterols and lanosterol among 30 postmenopausal women with repeat blood samples in the European Prospective Investigation into Cancer and Nutrition (EPIC) - Heidelberg, Germany cohort. Liquid chromatography-mass spectrometry (LC/MS) was performed to quantify serum concentrations of 22R-hydroxycholesterol, 25-hydroxycholesterol, 24S-hydroxycholesterol, 27-hydroxycholesterol, 22S-hydroxycholeterol, 24,25-epoxycholesterol, 5α,6β-dihydroxycholestanol, 7α-hydroxycholesterol, 5β,6β-epoxycholesterol, 5α,6α-epoxycholesterol, 24-dihydrolanosterol, and lanosterol. We evaluated Spearman correlations and intraclass correlation coefficients (ICCs) between quantifiable concentrations measured in repeat samples taken one-year apart to estimate within-person reproducibility.
RESULTS: Spearman correlations (ICCs) over one year ranged from 0 (ICC=0.10) for 5β,6β-epoxycholesterol and 0.10 (ICC=0.20) for 5α,6α-epoxycholesterol, representing low within-person stability, to 0.81 (ICC=0.75) for 27-hydroxycholesterol and 0.86 (ICC=0.91) for 24S-hydroxycholesterol, representing relatively high within-person stability. Correlations between oxysterols and lanosterol ranged from 0.01 between 24S-hydroxycholesterol and lanosterol to 0.70 between 5α,6α-epoxycholesterol and 5β,6β-epoxycholesterol.
CONCLUSIONS: Our results demonstrate that for 27-hydroxycholesterol, 24S-hydroxycholesterol, 25-hydroxycholesterol, 7α-hydroxycholesterol and lanosterol, a single serum measurement can reliably estimate average levels over a one-year period. Circulating oxysterols are of increasing interest in epidemiologic studies of chronic disease risk including cancer and cardiovascular disease. Our data suggest that within-person stability of oxysterols differs depending on the individual oxysterol evaluated. We identified four oxysterols and lanosterol as stable over time to inform the use of circulating oxysterols in epidemiologic studies.
Copyright © 2017 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholesterol metabolites; Lanosterol; Oxysterols; Within-person reproducibility

Mesh:

Substances:

Year:  2017        PMID: 29108727     DOI: 10.1016/j.clinbiochem.2017.11.001

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  7 in total

1.  miR-204 functions as a tumor suppressor gene, at least partly by suppressing CYP27A1 in glioblastoma.

Authors:  Jun Xin; Li-Min Zheng; De-Ke Sun; Xian-Feng Li; Peng Xu; Li-Qiang Tian
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

2.  Circulating SH2B1 is associated with an increased risk of gastric cancer.

Authors:  Bo Liu; Feng Li; Hong-Peng Zhao; Jing-Bo Chen; Yu-Peng Li; Hai-Hua Yu
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

3.  Circulating 27-hydroxycholesterol and Risk of Colorectal Adenomas and Serrated Polyps.

Authors:  Michael N Passarelli; Bonne M Thompson; Jeffrey G McDonald; Dale C Snover; Thomas J Palys; Judy R Rees; Elizabeth L Barry; John A Baron
Journal:  Cancer Prev Res (Phila)       Date:  2021-01-06

4.  Oncogenic roles of the cholesterol metabolite 25-hydroxycholesterol in bladder cancer.

Authors:  Chen Wang; Haowei He; Wennian Fang
Journal:  Oncol Lett       Date:  2020-03-27       Impact factor: 2.967

5.  The oncogenic roles of 27-hydroxycholesterol in glioblastoma.

Authors:  Lu Liu; Mei-Yuan Li; Yu Xing; Xiao-Yun Wang; Yong Wang
Journal:  Oncol Lett       Date:  2019-07-31       Impact factor: 2.967

6.  miR-204 reverses temozolomide resistance and inhibits cancer initiating cells phenotypes by degrading FAP-α in glioblastoma.

Authors:  Yun-Na Yang; Xiang-Hua Zhang; Yan-Ming Wang; Xi Zhang; Zheng Gu
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

7.  Human HLA‑F adjacent transcript 10 promotes the formation of cancer initiating cells and cisplatin resistance in bladder cancer.

Authors:  Chen Li; Zhenfan Wang; Ninghan Feng; Jian Dong; Xiaoyan Deng; Yin Yue; Yuehong Guo; Jianquan Hou
Journal:  Mol Med Rep       Date:  2018-05-09       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.